Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. From left to right: Michael ...

Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients ...

Lexaria’s after-hours surge came after the company filed with the Securities and Exchange Commission on Thursday, revealing that it had ended its “Capital on Demand” Sales Agreement with JonesTrading ...

A while ago I did a review of the first LEXX DVD, S2 V1, and promised to do the rest of the second season in the coming weeks. How can I put this delicately... I lied. It's been months. But I'm ...

Over the last two months, Lexaria Bioscience Corporation (NASDAQ:LEXX) has advanced several new initiatives, reported first quarter earnings and outlined a bold plan for 2022 which includes the launch ...